Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Locoregional Recurrence × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1645 Carcinoma, Non-Small-Cell Lung 1159 Prostatic Neoplasms 875 Colorectal Neoplasms 738 Multiple Myeloma 644 Leukemia, Myeloid, Acute 620 Lung Neoplasms 594 Neoplasms 590 Neoplasm Metastasis 559 Lymphoma 504 Pancreatic Neoplasms 496 Carcinoma, Hepatocellular 489 Stomach Neoplasms 456 Leukemia 450 Recurrence 434 Melanoma 393 Leukemia, Lymphocytic, Chronic, B-Cell 393 Precursor Cell Lymphoblastic Leukemia-Lymphoma 383 Lymphoma, Non-Hodgkin 379 Ovarian Neoplasms 377 Myelodysplastic Syndromes 364 Squamous Cell Carcinoma of Head and Neck 362 Lymphoma, Large B-Cell, Diffuse 359 Brain Neoplasms 359 Head and Neck Neoplasms 353 Rectal Neoplasms 341 Glioblastoma 336 Carcinoma, Renal Cell 301 Hodgkin Disease 295 Esophageal Neoplasms 291

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡